Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its participation in two upcoming investor conferences in September 2025. Management will present at the Wells Fargo 20th Annual Healthcare Conference on September 3rd at 9:30 a.m. ET and the H.C. Wainwright 27th Annual Global Investment Conference on September 9th at 10:30 a.m. ET.
Investors can access live webcasts of both presentations through the events section of the Tarsus website. Replay recordings will be available within 48 hours and archived for a limited time.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha comunicato la sua partecipazione a due conferenze per investitori previste a settembre 2025. La direzione terr脿 una presentazione al Wells Fargo 20th Annual Healthcare Conference il 3 settembre alle 9:30 ET e al H.C. Wainwright 27th Annual Global Investment Conference il 9 settembre alle 10:30 ET.
Gli investitori potranno seguire entrambe le presentazioni in diretta tramite webcast nella sezione eventi del sito di Tarsus. Le registrazioni saranno disponibili in replay entro 48 ore e saranno archiviate per un periodo limitato.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha anunciado su participaci贸n en dos conferencias para inversores en septiembre de 2025. La direcci贸n presentar谩 en el Wells Fargo 20th Annual Healthcare Conference el 3 de septiembre a las 9:30 a.m. ET y en el H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre a las 10:30 a.m. ET.
Los inversores podr谩n acceder a las retransmisiones en directo de ambas presentaciones a trav茅s de la secci贸n de eventos del sitio web de Tarsus. Las grabaciones estar谩n disponibles en replay en un plazo de 48 horas y se archivar谩n por tiempo limitado.
Tarsus Pharmaceuticals (NASDAQ: TARS)電� 2025雲� 9鞗� 鞓堨爼霅� 霊� 瓯挫潣 韴瀽鞛� 旖橅嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 瓴届榿歆勳潃 Wells Fargo 20th Annual Healthcare Conference鞐愳劀 9鞗� 3鞚� 鞓れ爠 9鞁� 30攵�(霃欕秬鞁滉皠)鞐�, H.C. Wainwright 27th Annual Global Investment Conference鞐愳劀 9鞗� 9鞚� 鞓れ爠 10鞁� 30攵�(霃欕秬鞁滉皠)鞐� 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� Tarsus 鞗轨偓鞚错姼鞚� 鞚措菠韸� 靹轨厴鞚� 韱淀暣 霊� 氚滍憸鞚� 霛检澊敫� 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟. 雼れ嫓氤搓赴 雲鬼檾電� 48鞁滉皠 鞚措偞鞐� 鞝滉车霅橂┌ 頃滌嫓鞝侅溂搿� 鞎勳勾鞚措笇霅╇媹雼�.
Tarsus Pharmaceuticals (NASDAQ: TARS) a annonc茅 sa participation 脿 deux conf茅rences investisseurs en septembre 2025. La direction pr茅sentera au Wells Fargo 20th Annual Healthcare Conference le 3 septembre 脿 9h30 ET et au H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre 脿 10h30 ET.
Les investisseurs pourront suivre les deux pr茅sentations en direct via des webcasts disponibles dans la rubrique 茅v茅nements du site de Tarsus. Les enregistrements seront accessibles en replay dans les 48 heures et archiv茅s pour une dur茅e limit茅e.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2025 angek眉ndigt. Das Management wird am Wells Fargo 20th Annual Healthcare Conference am 3. September um 9:30 Uhr ET und am H.C. Wainwright 27th Annual Global Investment Conference am 9. September um 10:30 Uhr ET pr盲sentieren.
Investoren k枚nnen beide Pr盲sentationen live 眉ber Webcasts im Bereich "Events" auf der Tarsus-Website verfolgen. Aufzeichnungen stehen innerhalb von 48 Stunden als Replay zur Verf眉gung und werden f眉r begrenzte Zeit archiviert.
- None.
- None.
IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:
- Wells Fargo 20th Annual Healthcare Conference on Wednesday, September 3rd, at 6:30 a.m. PT / 9:30 a.m. ET
- H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9th, at 7:30 a.m. PT / 10:30 a.m. ET
Live webcasts and additional information can be accessed on the events section of the Tarsus . Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY庐 (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
FAQ
When is Tarsus Pharmaceuticals (TARS) presenting at the Wells Fargo Healthcare Conference 2025?
When is the H.C. Wainwright Conference presentation for Tarsus (TARS)?
How can investors access Tarsus (TARS) conference presentations?
Which investor conferences is Tarsus Pharmaceuticals (TARS) attending in September 2025?
